Page 42 - Read Online
P. 42

Zhang et al. Ageing Neur Dis 2022;2:16  https://dx.doi.org/10.20517/and.2022.15  Page 7 of 11

                                                                                                      [88,89]
                CRISPR/Cas9 ROSA 26        KI             Safe harbor gene
                                                                                                      [90]
                BE3      MSTN              p.Q93stop      Muscle hypertrophy
                         TYR               p.Q68stop      Oculocutaneous albinism
                ABE7.10  DMD               p.T279A        Duchenne muscular dystrophy
                                                                                                      [91]
                eAID-    TYR               p.R299H        Oculocutaneous albinism
                BE4max
                                                                                                      [92]
                YFE-BE4max  TYR            p.Q68Stop      Oculocutaneous albinism
                                                                                                      [93]
                nNme2-CBE  FGF5            p.Q79Stop      Long hair
                                                                                                      [94]
                eA3G-BE  TYR               p.Q48stop      Oculocutaneous albinism
                                                                                                      [95]
                NG-ABEmax  HOXC13          p.Q271R        Hair and nail ectodermal dysplasia
                                                                                                      [96]
                BE4max   FGF5              Start Codon    Long hair
                                           Disruption
                ABE8.17  TYR               p.T325A        Oculocutaneous albinism                     [97]
                         LMNA              p.L530P        Emery-Dreifuss muscular dystrophy
                PE3      HEXA              p.Y427fs       Tay-Sachs disease                           [98]


               PROSPECTS AND LIMITATIONS FOR EVALUATING RABBIT DISEASE MODELS
               The observation of the clinical phenotypes of diseases is important for the evaluation of animal models.
               However, unlike the well-developed testing platforms for rodent models, currently, the evaluation criteria
               for rabbit NDD models are not well established.


               In general, the diagnosis, prognosis, and autopsy criteria in human NDDs can be used in animal models.
               Such investigations can provide data that are comparable to human clinical reports and have better
               referential value. Indeed, commercialized analysis platforms, such as serological testing, enzyme-linked
               immunosorbent assay, MRI, electromyography, and histological analysis, are versatile and authentic tools
               for the assessment of both humans and animals including rabbits. However, it is impossible to apply the
               whole set of human diagnostic criteria to animals. For example, the investigation methods for behavioral
               and cognitive analyses in humans are hard to apply in animal models. Standardized and species-specific
               behavioral analysis platforms can support the assessment of animal disease models. For rodents, systematic
               behavioral analysis systems are well established and standardized; systems such as multivariate concentric
                                                                                             [106]
               square field and cylinder test are used to investigate traits such as sensory-motor function . In contrast,
               the behavioral and cognitive analysis platforms for rabbits are not well developed at present, and further
               development of these systems is necessary for the future use of rabbits in neurological disease modeling.


               CONCLUSION
               Collectively, rabbits are more similar to humans in brain development, with more genetic similarities than
               rodents, and longer lifespan and larger body size, suggesting that rabbits can perform well in human
               neurological disease modeling in addition to traditional non-human primates, large animals, and rodent
               models. Therefore, it is expected that, in the near future, with the further development of genome editing
               technology and the establishment of phenotype assessment platforms for rabbit models, the value of rabbits
               in the research of neurological diseases can be maximized, not only for the understanding of pathological
               mechanisms but also for innovation of therapeutic approaches.

               DECLARATIONS
               Authors’ contributions
               Made substantial contributions to conception and design of the study and performed data analysis and
               interpretation: Zhang Z, Song Y
   37   38   39   40   41   42   43   44   45   46   47